{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:12:56Z","timestamp":1782331976784,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.pcl.2014.03.009","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T01:02:19Z","timestamp":1400547739000},"page":"607-620","source":"Crossref","is-referenced-by-count":22,"title":["Allergic Eye Disease"],"prefix":"10.1016","volume":"61","author":[{"given":"Virginia","family":"Miraldi Utz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pcl.2014.03.009_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaci.2010.06.050","article-title":"The epidemiology of ocular and nasal allergy in the United States, 1988-1994","volume":"126","author":"Singh","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.pcl.2014.03.009_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11882-002-0060-8","article-title":"The clinical spectrum of ocular allergy","volume":"2","author":"Bremond-Gignac","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.pcl.2014.03.009_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clae.2008.07.003","article-title":"The pathophysiology of ocular allergy: a review","volume":"32","author":"Chigbu","year":"2009","journal-title":"Cont Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.pcl.2014.03.009_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11882-012-0252-9","article-title":"Diagnostics and new developments in the treatment of ocular allergies","volume":"12","author":"Kari","year":"2012","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.pcl.2014.03.009_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09286580802573177","article-title":"Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population","volume":"16","author":"Lambiase","year":"2009","journal-title":"Ophthalmic Epidemiol"},{"issue":"5","key":"10.1016\/j.pcl.2014.03.009_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/ACI.0b013e3282ef6937","article-title":"Classification of ocular allergy","volume":"7","author":"Hodges","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.pcl.2014.03.009_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1398-9995.2007.01414.x","article-title":"The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis","volume":"62","author":"Hu","year":"2007","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.pcl.2014.03.009_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.eye.6700675","article-title":"Vernal keratoconjunctivitis","volume":"18","author":"Bonini","year":"2004","journal-title":"Eye (Lond)"},{"issue":"Suppl 78","key":"10.1016\/j.pcl.2014.03.009_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1398-9995.2004.00570.x","article-title":"Atopic keratoconjunctivitis","volume":"59","author":"Bonini","year":"2004","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.pcl.2014.03.009_bib10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0161-6420(90)32477-6","article-title":"Atopic keratoconjunctivitis","volume":"97","author":"Foster","year":"1990","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.pcl.2014.03.009_bib11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0161-6420(96)30591-5","article-title":"Asthma caused by topical application of ketorolac","volume":"103","author":"Sitenga","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pcl.2014.03.009_bib12","first-page":"205","article-title":"Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs","volume":"99","author":"Flach","year":"2001","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"8","key":"10.1016\/j.pcl.2014.03.009_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1185\/030079904125004321","article-title":"Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference","volume":"20","author":"Leonardi","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.pcl.2014.03.009_bib14","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1185\/030079904125004330","article-title":"Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model","volume":"20","author":"Lanier","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.pcl.2014.03.009_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1081-1206(10)62292-2","article-title":"Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms","volume":"86","author":"Lanier","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3 Pt 1","key":"10.1016\/j.pcl.2014.03.009_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0091-6749(94)90201-1","article-title":"Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis","volume":"94","author":"Abelson","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.pcl.2014.03.009_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0161-6420(95)31023-8","article-title":"Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model","volume":"102","author":"Abelson","year":"1995","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.pcl.2014.03.009_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/17425255.4.4.453","article-title":"Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing","volume":"4","author":"Abelson","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"10.1016\/j.pcl.2014.03.009_bib19","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1185\/030079904X5724","article-title":"Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model","volume":"20","author":"Abelson","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.pcl.2014.03.009_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/112067219400400203","article-title":"Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis","volume":"4","author":"Abelson","year":"1994","journal-title":"Eur J Ophthalmol"},{"issue":"230","key":"10.1016\/j.pcl.2014.03.009_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1600-0420.2000.078s230060.x","article-title":"An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution 0.1%) compared to Claritin (loratadine 10 mg) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model","author":"Abelson","year":"2000","journal-title":"Acta Ophthalmol Scand Suppl"},{"issue":"5","key":"10.1016\/j.pcl.2014.03.009_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1755-3768.2008.01265.x","article-title":"Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial","volume":"87","author":"Borazan","year":"2009","journal-title":"Acta Ophthalmol"},{"issue":"228","key":"10.1016\/j.pcl.2014.03.009_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0420.1999.tb01174.x","article-title":"Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model","author":"Deschenes","year":"1999","journal-title":"Acta Ophthalmol Scand Suppl"},{"issue":"228","key":"10.1016\/j.pcl.2014.03.009_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0420.1999.tb01173.x","article-title":"Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis","author":"Discepola","year":"1999","journal-title":"Acta Ophthalmol Scand Suppl"},{"issue":"3","key":"10.1016\/j.pcl.2014.03.009_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/112067219200200306","article-title":"Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study","volume":"2","author":"Fahy","year":"1992","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.pcl.2014.03.009_bib26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archopht.1990.01070060068051","article-title":"Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"Pt B","key":"10.1016\/j.pcl.2014.03.009_bib27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/978-1-4615-0717-8_47","article-title":"Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect","volume":"506","author":"Welch","year":"2002","journal-title":"Adv Exp Med Biol"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395514000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395514000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T16:28:01Z","timestamp":1565454481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395514000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0031395514000248"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2014.03.009","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}